首页> 外文期刊>European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology >Cortical thickness, cortical surface area and subcortical volumes in schizophrenia and bipolar disorder patients with cannabis use
【24h】

Cortical thickness, cortical surface area and subcortical volumes in schizophrenia and bipolar disorder patients with cannabis use

机译:精神分裂症和双相障碍患者的皮质厚度,皮质表面积和皮质体积大麻使用

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Cannabis is associated with increased risk for severe mental illness and is commonly used among individuals with schizophrenia or bipolar disorder. In this study we investigated associations between cannabis use and brain structures among patients with schizophrenia or bipolar disorders. Magnetic resonance imaging scans were obtained for 77 schizophrenia and 55 bipolar patients with a history of cannabis use (defined as lifetime use >10 times during one month or abuse/dependence), and 97 schizophrenia, 85 bipolar disorder patients and 277 healthy controls without any previous cannabis use. Cortical thickness, cortical surface area and subcortical volumes were compared between groups. Both hypothesis-driven region-of-interest analyses from 11 preselected brain regions in each hemisphere and exploratory point-by-point analyses were performed. We tested for diagnostic interactions and controlled for potential confounders. After controlling for confounders such as tobacco use and alcohol use disorders we found reduced cortical thickness in the caudal middle frontal gyrus compared to non-user patients and healthy controls. The findings were not significant when patients with co-morbid alcohol and illicit drug use were excluded from the analyses, but onset of cannabis use before illness onset was associated with cortical thinning in the caudal middle frontal gyrus. To conclude, we found no structural brain changes associated with cannabis use among patients with severe mental illness, but the findings indicate excess cortical thinning among those who use cannabis before illness onset. The present findings support the understanding that cannabis use is associated with limited brain effects in schizophrenia as well as bipolar disorder.
机译:摘要大麻与严重精神疾病的风险增加有关,并且通常在具有精神分裂症或双相障碍的个体中使用。在这项研究中,我们调查了精神分裂症或双相障碍患者的大麻使用和脑结构之间的关联。获得77个精神分裂症和55名双极性患者的磁共振成像扫描,其中大麻使用历史(在一个月或滥用/依赖期间定义为10次> 10次),97例精神分裂症,85名双相情感障碍患者和277名健康控制,没有任何以前的大麻使用。在组之间比较皮质厚度,皮质表面积和皮质波动体积。在每个半球和探索性点分析中,进行了从11个预选的脑区域的假设驱动的兴趣区域分析。我们测试了诊断互动并对潜在的混乱进行控制。在控制诸如烟草使用和酒精使用障碍之类的混淆之后,我们发现与非用户患者和健康对照相比,在尾部前阶段中发现减少皮质厚度。当患有共同病态酒精和非法药物用途的患者被排除在分析中时,结果并不重要,但在疾病发病之前的大麻使用的发生与尾部中正面回到的皮质稀疏相关。为了得出结论,我们发现没有与患有严重精神疾病的患者大麻的结构脑改变,但结果表明在疾病发作前使用大麻的那些患者中的过度皮质变薄。本研究结果支持理解,大麻使用与精神分裂症和双相障碍有限的大脑作用相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号